Duke/UNC CTSA Consortium Grants

This pilot program is designed to encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings.

Cross-disciplinary basic research addressing the development of therapies, diagnostics or devices applicable to human disease and clinical research/trials are areas of interest for these awards. Projects must demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels.

Proposed projects must involve a lead investigator from Duke and a lead investigator from UNC-Chapel Hill. Proposals are encouraged from new teams of investigators from different disciplines. Applicants at each institution must have a full-time faculty appointment.

The research activities at each participating institution will be funded by that institution's CTSA. Duke CTSI and NC TraCS will each fund up to $25,000 direct costs, for a total of $50,000 per collaborative project.

The budget period is for 12 months beginning between January 1 and May 1, 2019 and ending no later than April 30, 2020. Proposals are submitted via the Duke CTSA online system – please see the RFA below for more information.

View the Duke/UNC CTSA Consortium RFA (pdf)

Submission Due Date

October 11, 2018